MONOCLONAL ANTIBODY FOR CANCER TREATMENT (Q3133637)
Jump to navigation
Jump to search
Project Q3133637 in Spain
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MONOCLONAL ANTIBODY FOR CANCER TREATMENT |
Project Q3133637 in Spain |
Statements
28,123.69 Euro
0 references
56,247.39 Euro
0 references
50.0 percent
0 references
16 February 2015
0 references
14 December 2015
0 references
ALTHIA HEALTH S.L.
0 references
40°25'0.12"N, 3°42'12.89"W
0 references
28079
0 references
VALIDACIÓN DE UN ANTICUERPO MONOCLONAL PARA LA DETECCIÓN Y TRATAMIENTO DE CÉLULAS MADRE DEL CÁNCER EN TUMORES DE CEREBRO (Spanish)
0 references
VALIDATION OF A MONOCLONAL ANTIBODY FOR THE DETECTION AND TREATMENT OF CANCER MOTHER CELLS IN BRAIN TUMORS (English)
0 references
VALIDATION D’UN ANTICORPS MONOCLONAL POUR LA DÉTECTION ET LE TRAITEMENT DES CELLULES SOUCHES CANCÉREUSES DANS LES TUMEURS CÉRÉBRALES (French)
2 December 2021
0 references
VALIDIERUNG EINES MONOKLONALEN ANTIKÖRPERS FÜR DEN NACHWEIS UND DIE BEHANDLUNG VON KREBSSTAMMZELLEN IN HIRNTUMOREN (German)
9 December 2021
0 references
Madrid
0 references
Identifiers
DGEPF/01/21/002-17/18
0 references